Clinical Trial

Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI

Name: Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI — clinical trial record (NCT07457541)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The study should evaluate the biological distribution of 99mTc-HYNIC-FAPI in metastatic cancer patients.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2026-03-03; most recent amendment 2026-06-24.

Trial Details

NCT Number	NCT07457541
Lead Sponsor	Tomsk National Research Medical Center of the Russian Academy of Sciences
Conditions	Lung Cancer (Locally Advanced or Metastatic), Pancreas Cancer, Metastatic, Breast Cancer (Locally Advanced or Metastatic), Colorectal Cancer (Locally Advanced or Metastatic)
Enrollment	15 participants
Start Date	2026-02-26
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-05-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-25